133 related articles for article (PubMed ID: 12767016)
1. Studies of neutralising antibodies to SV40 in human sera.
Minor P; Pipkin P; Jarzebek Z; Knowles W
J Med Virol; 2003 Jul; 70(3):490-5. PubMed ID: 12767016
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the occurrence of SV40 antibodies in South Africa.
Basetse HR; Lecatsas G; Gerber LJ
S Afr Med J; 2002 Oct; 92(10):825-8. PubMed ID: 12432810
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
Lundstig A; Eliasson L; Lehtinen M; Sasnauskas K; Koskela P; Dillner J
J Gen Virol; 2005 Jun; 86(Pt 6):1703-1708. PubMed ID: 15914848
[TBL] [Abstract][Full Text] [Related]
5. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
[TBL] [Abstract][Full Text] [Related]
6. Simian virus 40 (SV40) and human cancer: a review of the serological data.
Shah KV; Galloway DA; Knowles WA; Viscidi RP
Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
[TBL] [Abstract][Full Text] [Related]
7. SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines.
Wong C; Zhang S; Adam E; Paszat L; Butel JS
J Infect; 2019 Jun; 78(6):476-483. PubMed ID: 30965068
[TBL] [Abstract][Full Text] [Related]
8. Public health. Creeping consensus on SV40 and polio vaccine.
Ferber D
Science; 2002 Oct; 298(5594):725-7. PubMed ID: 12399560
[No Abstract] [Full Text] [Related]
9. Polyomavirus SV40 infections in Kazakhstan.
Nurgalieva ZZ; Wong C; Zhangabylov AK; Omarbekova ZE; Graham DY; Vilchez RA; Butel JS
J Infect; 2005 Feb; 50(2):142-8. PubMed ID: 15667916
[TBL] [Abstract][Full Text] [Related]
10. Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.
Taronna A; Mazzoni E; Corallini A; Bononi I; Pietrobon S; Guerra G; Palmonari C; Borgna-Pignatti C; Comar M; Bovenzi M; Casali F; Marci R; Rezza G; Barbanti-Brodano G; Tognon M; Martini F
PLoS One; 2013; 8(4):e61182. PubMed ID: 23634207
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Engels EA; Viscidi RP; Galloway DA; Carter JJ; Cerhan JR; Davis S; Cozen W; Severson RK; de Sanjose S; Colt JS; Hartge P
J Natl Cancer Inst; 2004 Sep; 96(18):1368-74. PubMed ID: 15367569
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus.
Chen T; Mattila PS; Jartti T; Ruuskanen O; Söderlund-Venermo M; Hedman K
J Infect Dis; 2011 Nov; 204(10):1523-6. PubMed ID: 21926381
[TBL] [Abstract][Full Text] [Related]
13. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults.
Jafar S; Rodriguez-Barradas M; Graham DY; Butel JS
J Med Virol; 1998 Apr; 54(4):276-84. PubMed ID: 9557293
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for SV40 in human cancer?
Poulin DL; DeCaprio JA
J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
[TBL] [Abstract][Full Text] [Related]
15. Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.
Tognon M; Corallini A; Manfrini M; Taronna A; Butel JS; Pietrobon S; Trevisiol L; Bononi I; Vaccher E; Barbanti-Brodano G; Martini F; Mazzoni E
PLoS One; 2016; 11(1):e0145720. PubMed ID: 26731525
[TBL] [Abstract][Full Text] [Related]
16. Lack of serological evidence for an association between simian virus 40 and lymphoma.
de Sanjose S; Shah KV; Domingo-Domenech E; Engels EA; Fernandez de Sevilla A; Alvaro T; Garcia-Villanueva M; Romagosa V; Gonzalez-Barca E; Viscidi RP
Int J Cancer; 2003 Apr; 104(4):522-4. PubMed ID: 12584752
[TBL] [Abstract][Full Text] [Related]
17. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children.
Mazzoni E; Frontini F; Rotondo JC; Zanotta N; Fioravanti A; Minelli F; Torreggiani E; Campisciano G; Marcuzzi A; Guerra G; Tommasini A; Touzé A; Martini F; Tognon M; Comar M
J Cell Physiol; 2019 Apr; 234(4):3170-3179. PubMed ID: 30362540
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.
Sroller V; Hamšíková E; Ludvíková V; Vochozková P; Kojzarová M; Fraiberk M; Saláková M; Morávková A; Forstová J; Němečková S
J Med Virol; 2014 Sep; 86(9):1560-8. PubMed ID: 24214630
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas.
Wong C; Vilchez RA; Quiroz J; Adam E; Butel JS
J Infect; 2013 Jan; 66(1):67-74. PubMed ID: 22940252
[TBL] [Abstract][Full Text] [Related]
20. SV40 and SV40-like viruses as possible risk factors.
Geissler E
Arch Geschwulstforsch; 1983; 53(3):217-26. PubMed ID: 6311136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
